BioCentury
ARTICLE | Company News

Jiangxi Aiqilin Pharmaceuticals, Uluru deal

July 5, 2010 7:00 AM UTC

Uluru granted Jiangxi rights to commercialize Altrazeal in China, Hong Kong, Macau and Taiwan. Uluru already markets the antimicrobial dressing incorporating the company's Nanoflex nanoparticle aggre...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article